These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1372645)

  • 1. Angiogenesis inhibition suppresses collagen arthritis.
    Peacock DJ; Banquerigo ML; Brahn E
    J Exp Med; 1992 Apr; 175(4):1135-8. PubMed ID: 1372645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis.
    Peacock DJ; Banquerigo ML; Brahn E
    Cell Immunol; 1995 Feb; 160(2):178-84. PubMed ID: 7536634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).
    Oliver SJ; Cheng TP; Banquerigo ML; Brahn E
    Cell Immunol; 1995 Dec; 166(2):196-206. PubMed ID: 7497521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol.
    Oliver SJ; Banquerigo ML; Brahn E
    Cell Immunol; 1994 Aug; 157(1):291-9. PubMed ID: 7518753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
    Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
    J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
    [No Abstract]   [Full Text] [Related]  

  • 6. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenesis in vivo by interleukin 12.
    Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
    J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis.
    Brem H; Gresser I; Grosfeld J; Folkman J
    J Pediatr Surg; 1993 Oct; 28(10):1253-7. PubMed ID: 7505321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470.
    Kido A; Tsujiuchi T; Morishita T; Tsutsumi M; Takahama M; Miyauchi Y; Mii Y; Tamai S; Konishi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1074-81. PubMed ID: 9849588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor.
    Brahn E; Banquerigo ML; Lee JK; Park EJ; Fogler WE; Plum SM
    J Rheumatol; 2008 Nov; 35(11):2119-28. PubMed ID: 18792999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.
    Schoof DD; Obando JA; Cusack JC; Goedegebuure PS; Brem H; Eberlein TJ
    Int J Cancer; 1993 Oct; 55(4):630-5. PubMed ID: 7691763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats.
    Takechi A
    Neurol Med Chir (Tokyo); 1994 Nov; 34(11):729-33. PubMed ID: 7533265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470.
    Berger AE; Dortch KA; Staite ND; Mitchell MA; Evans BR; Holm MS
    Agents Actions; 1993; 39 Spec No():C86-8. PubMed ID: 8273596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects.
    Morishita T; Miyauchi Y; Mii Y; Miura S; Honoki K; Aoki M; Kido A; Yoshimoto M; Tamai S; Tsutsumi M; Konishi Y
    Clin Exp Metastasis; 1999 Feb; 17(1):15-8. PubMed ID: 10390142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470.
    Klauber N; Rohan RM; Flynn E; D'Amato RJ
    Nat Med; 1997 Apr; 3(4):443-6. PubMed ID: 9095179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of coronary vasculitis in a murine model of Kawasaki disease using an angiogenesis inhibitor.
    Brahn E; Lehman TJ; Peacock DJ; Tang C; Banquerigo ML
    Clin Immunol; 1999 Jan; 90(1):147-51. PubMed ID: 9884364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of the anti-angiogenesis drug TNP-470.
    Gervaz P; Fontolliet C
    Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.
    Maier JA; Delia D; Thorpe PE; Gasparini G
    Anticancer Drugs; 1997 Mar; 8(3):238-44. PubMed ID: 9095328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470.
    Futami H; Iseki H; Egawa S; Koyama K; Yamaguchi K
    Invasion Metastasis; 1996; 16(2):73-82. PubMed ID: 9030242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.